Push for more detail on COVID-19 oral antivirals impact Experts highlight ‘crucial’ need for more understanding about how newly released oral antiviral drugs are performing in the broader population.
First COVID-19 antiviral receives PBS funding GPs can now prescribe molnupiravir for COVID-positive adult patients at risk of developing severe disease.
What GPs need to know about the new COVID antivirals Both oral antiviral COVID-19 treatments are now available, with significant restrictions, on the PBS.
Do current COVID-19 vaccines and treatments neutralise Omicron? New research has looked into a number of medications currently approved for use in Australia, as well as the role of a booster shot against the highly-infectious variant.
COVID-19 antiviral pills to be reserved primarily for the unvaccinated Despite TGA approval last month, the two new COVID-19 treatments developed by Pfizer and Merck will not be widely available for prescription in the short-term.
Australia secures 300,000 courses of COVID antiviral The supply agreement could mean molnupiravir is being used to treat COVID-19 by early 2022, provided it is approved by the TGA.
GPs could soon have an antiviral pill to treat COVID-19 A new oral treatment reduces the risk of hospitalisation and death due to COVID by 50%, research suggests.